what is tirzepatide approved for Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) now FDA-approved children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. this means ⬇️ Tirzepatide approved for weight loss
Description
El K, Douros JD, Willard FS, Novikoff A, Sargsyan A, Perez-Tilve D, et al
These are the most common early side effects and typically resolve within two to three weeks
Endocr J
In bone, GIP promotes bone formation, while GLP-1 inhibits bone reabsorption
But go in with realistic expectations
Soaring use of the medications has pushed up costs for employers, some of whom plan to tell employees they will no longer pay for them in 2027, industry experts say
